Augustin Vannier
Papers
1
Total Citations
7
H-Index
1
About
Dr. Augustin Vannier is a leading oncologist and translational researcher whose work focuses on human papillomavirus-associated (HPV+) oropharyngeal cancer, with a particular emphasis on biomarker-driven treatment de-escalation. His major contribution lies in pioneering the use of circulating tumor HPV DNA (ctHPV-DNA) as a dynamic, noninvasive biomarker to guide response-adapted therapy. In his highly cited 2025 study, Dr. Vannier demonstrated that early ctHPV-DNA kinetics during neoadjuvant chemotherapy can identify patients with excellent prognosis, enabling safe reductions in treatment intensity to minimize long-term toxicity without compromising survival. This work has garnered 7 citations and represents a paradigm shift toward precision de-escalation in head and neck oncology. His research bridges molecular diagnostics and clinical decision-making, offering a tangible path to reduce the burden of curative-intent therapy. Dr. Vannier’s contributions are shaping the future of personalized cancer care, making him a key figure in the effort to improve quality of life for survivors of HPV-driven malignancies.
Research Focus
Key Achievements
Top Papers
- 1